Literature DB >> 9085196

Regional distribution of specific high affinity binding sites for 3H-imipramine and 3H-paroxetine in human brain.

P Rosel1, J M Menchon, M Oros, J Vallejo, T Cortadellas, B Arranz, P Alvarez, M A Navarro.   

Abstract

The binding of 3H-paroxetine and 3H-imipramine has been compared in 17 different regions of 12 human control brains. Our findings reveal that the regional distribution is similar for both radioligands and their bindings tend to be parallel in the brain. The highest binding site density was found in basal ganglia (hypothalamus Bmax 780 +/- 102 fmol/mg protein for 3H-imipramine binding and Bmax 515 approximately 83 for 3H-paroxetine binding). The lowest values were found in cortical areas (cingulate cortex 191 +/- 18.5 fmol/mg for 3H-imipramine binding and 88 +/- 7.5 fmol/mg for 3H-paroxetine binding). The Kd values for 3H-paroxetine binding to neuronal membranes were similar in all brain regions (mean +/- s.d. Kd 0.07 +/- 0.007 nM) and also for 3H-imipramine binding (mean +/- s.d. Kd 1.05 +/- 0.12 nM). As these values are the same as in platelet membrane, the results obtained indicate that both binding sites are identical in neuronal and in platelet membranes. These findings suggest that both ligands are good markers of the 5HT transporter. However, the higher affinity of 3H-paroxetine confirms that this compound is a better radioligand for the 5HT uptake site.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9085196     DOI: 10.1007/BF01271297

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  35 in total

1.  A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples.

Authors:  M A Markwell; S M Haas; L L Bieber; N E Tolbert
Journal:  Anal Biochem       Date:  1978-06-15       Impact factor: 3.365

2.  Different components of 3H-imipramine binding in rat brain membranes: relation to serotonin uptake sites.

Authors:  M Gobbi; C Taddei; T Mennini
Journal:  Life Sci       Date:  1988       Impact factor: 5.037

3.  Human platelets possess high-affinity binding sites for 3H-imipramine.

Authors:  M S Briley; R Raisman; S Z Langer
Journal:  Eur J Pharmacol       Date:  1979-10-01       Impact factor: 4.432

4.  Differentiation of two components of specific [3H]imipramine binding in rat brain.

Authors:  P D Hrdina
Journal:  Eur J Pharmacol       Date:  1984-07-20       Impact factor: 4.432

5.  Regional distribution of [3H]imipramine binding in rat brain.

Authors:  M Palkovits; R Raisman; M Briley; S Z Langer
Journal:  Brain Res       Date:  1981-04-06       Impact factor: 3.252

6.  Does high affinity [3H] imipramine binding label serotonin reuptake sites in brain and platelet?

Authors:  S M Paul; M Rehavi; K C Rice; Y Ittah; P Skolnick
Journal:  Life Sci       Date:  1981-06-15       Impact factor: 5.037

7.  Association of [3H]-imipramine and [3H]-paroxetine binding with the 5HT transporter in brain and platelets: relevance to studies in depression.

Authors:  S Z Langer; A M Galzin; M F Poirier; H Loo; D Sechter; E Zarifian
Journal:  J Recept Res       Date:  1987

8.  Regional distribution of the serotonin transport complex in human brain, identified with 3H-paroxetine, 3H-citalopram and 3H-imipramine.

Authors:  P Plenge; E T Mellerup; H Laursen
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1990       Impact factor: 5.067

9.  5-Hydroxytryptamine-sensitive [3H]imipramine binding of protein nature in the human brain. II. Effect of normal aging and dementia disorders.

Authors:  J O Marcusson; I Alafuzoff; I T Bäckström; E Ericson; C G Gottfries; B Winblad
Journal:  Brain Res       Date:  1987-11-03       Impact factor: 3.252

10.  3H-imipramine binding and serotonin uptake in platelets from untreated depressed patients and control volunteers.

Authors:  R Raisman; M S Briley; F Bouchami; D Sechter; E Zarifian; S Z Langer
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

View more
  3 in total

1.  PET imaging of the brain serotonin transporters (SERT) with N,N-dimethyl-2-(2-amino-4-[18F]fluorophenylthio)benzylamine (4-[18F]-ADAM) in humans: a preliminary study.

Authors:  Wen-Sheng Huang; San-Yuan Huang; Pei-Shen Ho; Kuo-Hsing Ma; Ya-Yao Huang; Chin-Bin Yeh; Ren-Syuan Liu; Cheng-Yi Cheng; Chyng-Yann Shiue
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-10-05       Impact factor: 9.236

2.  High affinity [3H]imipramine and [3H]paroxetine binding sites in suicide brains.

Authors:  P Rosel; B Arranz; J Vallejo; M Oros; J M Menchón; P Alvarez; M A Navarro
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

3.  Tracer kinetic modeling of [(11)C]AFM, a new PET imaging agent for the serotonin transporter.

Authors:  Mika Naganawa; Nabeel Nabulsi; Beata Planeta; Jean-Dominique Gallezot; Shu-Fei Lin; Soheila Najafzadeh; Wendol Williams; Jim Ropchan; David Labaree; Alexander Neumeister; Yiyun Huang; Richard E Carson
Journal:  J Cereb Blood Flow Metab       Date:  2013-08-07       Impact factor: 6.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.